Clinical Trials
220 trialsGRIPS
University Hospital Heidelberg
NEURO-SUTURE
Medical University of Warsaw
PIRe
Rigshospitalet, Denmark
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Washington University School of Medicine
A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
SonoClear AS
PORTRAIT
The Christie NHS Foundation Trust
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Mayo Clinic
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Eastern Cooperative Oncology Group
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
University of Maryland, Baltimore
Precision Radiotherapy Enabled by Molecular MRI
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
MELODY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients
UNC Lineberger Comprehensive Cancer Center
NK Cell Therapy for Malignant Solid Brain Tumors
Peking University Third Hospital
Investigational Imaging Technique During Brain Surgery
Emory University
POSEIDON
Centre Antoine Lacassagne
TYR-GLIO
Copernicus Memorial Hospital
STEMRI
Institut Claudius Regaud
ATTRACT
Medical University of Vienna
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma
Waikato Hospital
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Alpha Tau Medical LTD.
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
Medical University of Warsaw
TMZ-CHRONO
Ottawa Hospital Research Institute
EF-32
NovoCure Ltd.
HipoGBM
Hospital do Coracao
GLAD
Wake Forest University Health Sciences
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
WBSI Guided Personalized Delivery of TTFields
Abramson Cancer Center at Penn Medicine
UNITED-4
Sunnybrook Health Sciences Centre
Supramarginal Resection in Glioblastoma
St. Olavs Hospital
Mind-Body Intervention in Glioma Couples
M.D. Anderson Cancer Center
BELGICA
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTSMILE
Royal College of Surgeons, Ireland
EXOFIELDS
Institut Claudius Regaud
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Mayo Clinic
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Shengjing Hospital
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
Ketones
Michigan State University
INDYGO
University Hospital, Lille
Limited Target Volume Radiotherapy After Glioblastoma Surgery
Jiangxi Provincial Cancer Hospital
Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma
Thomas Jefferson University
GCCC 19140
University of Maryland, Baltimore
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
M.D. Anderson Cancer Center
SPECTROBEVA
Centre Hospitalier Universitaire, Amiens
CTRL COH
Hospices Civils de Lyon